SLILATY STEVE N. (Chief Executive Officer) received a stock award from SUNSHINE BIOPHARMA INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/16/2021ACC: 0001128732-21-000002
DirectorOfficer· Chief Executive Officer
Since Aug 2018
+20M
Net shares
Net buyer
$20.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
20M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20M
Price / share
$0.00
Trade value
$20K
% of position
598.2%
1/6/2021
3.34M→23.34M
Total
Net shares
+20M
Net value
$20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2021 | A · Award | +20M | $0.00 | $20K | 598.2% | 3.34M | 23.34M |
| Total | +20M | $20K | ||||||
Derivative Transactions0
No derivative transactions reported